Gross Margin

As DarioHealth prepares its Q2 results, investors are watching closely. Can its disciplined cost-cutting and AI-powered platform deliver on the promise of profitability?

A deep dive into RBC Bearings' stellar quarter reveals more than just sales growth. Record backlogs and soaring defense demand signal a new era of growth.

As Acorn Energy prepares for its Q2 earnings call, investors are focused on volatile revenue. But the real story is its quiet expansion into securing our vital infrastructure.

The AI firm used a strategic maneuver to avoid delisting, but does its pivot to enterprise AI signal a true recovery or just a temporary market fix?

Apple posted its strongest June quarter ever, but a cautious forecast and warnings of critical supply constraints sent its stock tumbling after hours.

A massive tariff refund inflated Columbia's earnings, masking U.S. weakness while its new strategy to woo younger shoppers shows early promise.

As CapsoVision preps its Q2 report, investors look past the numbers to its AI-driven pipeline, a key test of its strategy to reshape GI diagnostics.

Despite a slight dip in sales, First Solar's profits soared in Q2. A closer look reveals a masterclass in strategy, leveraging domestic manufacturing.

Spineway secures €1.5M in crucial financing amid rising losses, betting on its innovative ESP® disc and surgeon education to finally turn revenue into profit.

As Vuzix prepares its Q2 2026 earnings call, investors will look past the numbers to a bigger question: can its pivot to an OEM model unlock its AR potential?

Data I/O reports a 59% sequential sales jump, but a surprise delay in its full earnings to analyze a complex $9M investment introduces critical uncertainty.

As Dollar General preps its Q2 earnings, all eyes are on what its results will reveal about inflation, consumer shifts, and the health of the U.S. economy.

The luxury outfitter's Q1 results beat expectations, yet a closer look reveals a brand grappling with softening store traffic and a looming trade war.

Regeneron's Q2 results reveal soaring sales from Dupixent and EYLEA HD, a pivotal pipeline, and a major financial reset with Sanofi. What's next?

The chocolate giant posted staggering Q2 earnings growth, but a closer look reveals a risky strategy of hiking prices that is eroding sales volumes.

USLM posts strong Q2 earnings by riding a wave of industrial demand, navigating high costs, and betting on the data center boom to offset a weak housing market.

NWPX Infrastructure posts record profits, but the real story is its diversified model, where a water systems boom masks a precast slump. A case study in resilience.

As Hamilton Beach sets its Q2 earnings call, the focus is less on kitchen gadgets and more on its strategic pivot into healthcare and commercial markets.

Lithia & Driveway defied market crosswinds with record Q2 revenue, a 17% EPS jump, and a 23% dividend hike, proving its integrated strategy is firing on all cylinders.

As Tidewater reports Q2 results, the market seeks clues on its navigation of market volatility, its strategic pivot to wind, and its consolidation endgame.